image credit: Adobe Stock

Biofourmis banks $300M megaround to fuel its growth in remote care, potential M&A deals

April 26, 2022


Three years ago, technology startup Biofourmis had raised $10 million in total funding. This week, the virtual care and digital medicine-focused company announced a massive $300 million cash injection to fuel its growth.

The funding round has boosted Biofourmis’ valuation to more than $1 billion, according to executives.

The series D investment was led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round.

Read More on FierceHealthcare